Jackson Financial Inc.

StockStory rates JXN “Underperform,” noting flat EPS over the last four years, sluggish net premiums earned growth, and a pre‑tax margin that has fallen into negative territory despite exceptional multi‑year revenue growth. The Q1 2026 update emphasizes a 22.6% year‑on‑year revenue decline, an adjusted EPS miss versus consensus, and concludes that the shares appear cheap for valid fundamental reasons, so investors are better off seeking higher‑quality opportunities.

This narrative aggregates recent Street research, highlighting consensus fair value around 124.75 dollars versus a share price near 105, with individual price targets ranging from 118 to 138 and modestly trimmed valuation assumptions. It stresses Jackson’s strong capital generation, potential tail‑risk reduction from a living‑benefits risk transfer, and robust buybacks and dividends as positives, while flagging hedging complexity, fee and margin pressure, asset‑quality risk, and regulatory scrutiny as ongoing concerns.

This article summarizes Danny Green’s bullish Substack thesis, arguing that JXN is a top U.S. annuity provider with a narrow but real moat rooted in its distribution network, strong free cash flow, and sizable capital returns via buybacks and dividends. It frames valuation as compelling on forward P/E and earnings‑yield metrics, suggesting meaningful upside if the market re‑rates the stock, while acknowledging that opaque hedging, GAAP earnings volatility, and product‑complexity risks require careful, long‑term oriented analysis.

Green’s deep dive concludes that JXN has a modest but tangible competitive advantage through broker and advisor relationships, solid adjusted operating ROE around 14%, and strong free cash flow of roughly 719 million in the first nine months of 2025 supporting aggressive buybacks and dividends. He views growth in RILA and annuity sales as real but cyclical, judges the shares as reasonably to undervalued on forward earnings and book value, and highlights GAAP volatility, hedging complexity, and interest‑rate sensitivity as the primary risks investors must be willing to tolerate.

Zacks assigns JXN a Rank 1 “Strong Buy,” citing projected EPS growth of about 17% for the current fiscal year, a forward P/E near 4.8, and a dividend yield around 3% within the life‑insurance peer group. The report emphasizes unanimous upward estimate revisions, a history of positive earnings surprises, and strong return on equity, while noting that sales are expected to contract in the near term and the business remains exposed to typical cyclical and capital‑intensive insurance risks.